Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02388 | Pages: NA | Charts: NA | Tables: NA |
Positron emission tomography-computed tomography (PET-CT) is a medical analytical technique used to examine the metabolic activity of tissues. This technique makes the use of PET scanner and an X-ray CT scanner. The PET scanners are used to measure body functions, such as blood flow, oxygen usage, and glucose metabolism, whereas CT imaging uses X-ray equipment to produce pictures of organs to observe the functioning of tissues and organs. The combined use of PET-CT scans provides the images of precise location of abnormal metabolic activity in the body.
The global PET-CT scanning market is segmented based on application, service provider, and geography. Applications covered in this study include oncology, neurology, cardiology, and others. On the basis of service provider, the market is categorized into hospitals, diagnostic centers, and research institutes. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The growth of the global PET-CT scanning market is driven by rise in prevalence of chronic illnesses throughout the world, growth in demand for effective diagnostic systems, and increased coverage for PET-CT scanning under Medicare. Rise in use of PET-CT for cancer diagnosis is expected to further boost the market growth. Moreover, development of newer products and increase in investments in R&D by companies contribute towards the revenue growth of the market. However, limited shelf life and inadequate availability of radiopharmaceuticals are expected to hinder the market growth.
Comprehensive competitive analysis and profiles of major market players such as Toshiba Corporation, General Electric Co, Hitachi, Siemens AG, Positron Corporation, Yangzhou Kindsway Biotech Co. Ltd, and Mediso Ltd are provided in this report.
Key Benefits
Key Market Segments
Key Market Players